Condition Lookup
Category:
Systemic Diseases with Renal Involvement
Number of Conditions: 7
Microscopic Polyangiitis
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Sub-category: Vasculitis with Kidney Involvement
Symptoms:
fatigue; fever; weight loss; hematuria (blood in urine); proteinuria; shortness of breath; cough with blood (hemoptysis); joint pain; skin purpura
Root Cause:
Autoimmune-mediated small-vessel vasculitis, characterized by inflammation without granuloma formation, leading to damage in kidneys, lungs, and skin.
How it's Diagnosed: videos
Diagnosis involves clinical assessment, ANCA serology (commonly p-ANCA/MPO-ANCA positive), urinalysis for renal involvement, imaging for lung involvement, and kidney biopsy confirming necrotizing vasculitis.
Treatment:
Similar to Granulomatosis with Polyangiitis, treatment focuses on inducing and maintaining remission with immunosuppressive therapy.
Medications:
Commonly prescribed medications include - Glucocorticoids (e.g., prednisone ) for inflammation control. Immunosuppressants (e.g., cyclophosphamide or azathioprine ) for autoimmune suppression. Biologics such as rituximab in refractory cases. Plasma Exchange for life-threatening complications like rapidly progressive glomerulonephritis.
Prevalence:
How common the health condition is within a specific population.
Rare; incidence is approximately 1–3 cases per 100,000 people per year.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Similar to Granulomatosis with Polyangiitis; includes genetic predisposition and environmental triggers.
Prognosis:
The expected outcome or course of the condition over time.
Better outcomes with early diagnosis and treatment; relapses are common, requiring long-term monitoring and management.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease, respiratory failure, infections due to immunosuppression, and thromboembolic events.
Diabetes Mellitus (Diabetic Nephropathy)
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Symptoms:
proteinuria (protein in the urine); swelling (edema) in the legs and ankles; elevated blood pressure; fatigue; nausea; frequent urination; unexplained weight loss
Root Cause:
Chronic high blood sugar levels damage the glomeruli in the kidneys, impairing their ability to filter waste and leading to progressive kidney dysfunction.
How it's Diagnosed: videos
Urine tests to detect proteinuria, blood tests for serum creatinine and estimated glomerular filtration rate (eGFR), kidney biopsy in unclear cases.
Treatment:
Blood sugar control via lifestyle changes and medications, blood pressure management, dietary modifications (e.g., low-protein diet), and supportive care to prevent progression.
Medications:
Angiotensin-converting enzyme (ACE) inhibitors (e.g., lisinopril ) or angiotensin II receptor blockers (ARBs) (e.g., losartan ) to reduce proteinuria and protect kidney function; sodium-glucose co-transporter-2 (SGLT2) inhibitors (e.g., empagliflozin ) to improve glycemic control and delay kidney damage; insulin or oral hypoglycemics (e.g., metformin ) for blood sugar management; diuretics to manage fluid retention.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 20–40% of individuals with diabetes; more common in long-standing Type 1 and Type 2 diabetes.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Poor blood sugar control, long duration of diabetes, hypertension, obesity, family history of kidney disease, smoking.
Prognosis:
The expected outcome or course of the condition over time.
Early-stage diabetic nephropathy can be slowed with proper management, but advanced stages may lead to end-stage renal disease (ESRD) requiring dialysis or transplantation.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease (CKD), end-stage renal disease (ESRD), cardiovascular disease, increased risk of infections.
Hypertension (Hypertensive Nephropathy)
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Symptoms:
elevated blood pressure; proteinuria; nocturia (frequent urination at night); swelling (edema); fatigue; headaches
Root Cause:
Chronic high blood pressure damages small blood vessels in the kidneys (arterioles), reducing their ability to filter waste and regulate blood pressure.
How it's Diagnosed: videos
Blood pressure measurements, urine tests to detect proteinuria, blood tests for serum creatinine and eGFR, renal ultrasound to assess kidney structure.
Treatment:
Blood pressure management through lifestyle changes and antihypertensive medications, dietary salt restriction, and monitoring kidney function to prevent further damage.
Medications:
ACE inhibitors (e.g., enalapril ) or ARBs (e.g., candesartan ) to lower blood pressure and protect kidney function; calcium channel blockers (e.g., amlodipine ) and beta-blockers (e.g., metoprolol ) for additional blood pressure control; diuretics (e.g., furosemide ) to reduce fluid overload.
Prevalence:
How common the health condition is within a specific population.
Approximately 10–15% of individuals with chronic hypertension develop hypertensive nephropathy; more common in older adults and those with poorly controlled hypertension.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Long-standing hypertension, African American ethnicity, obesity, high dietary salt intake, family history of kidney disease.
Prognosis:
The expected outcome or course of the condition over time.
With early detection and aggressive blood pressure control, progression to chronic kidney disease can be slowed. Advanced disease may lead to ESRD requiring dialysis or transplantation.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease (CKD), end-stage renal disease (ESRD), cardiovascular complications such as heart failure or stroke, increased risk of infections.
Granulomatosis with Polyangiitis (Wegener's)
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Sub-category: Vasculitis with Kidney Involvement
Symptoms:
fatigue; fever; weight loss; sinusitis; nasal crusting; hematuria (blood in urine); shortness of breath; joint pain; skin rashes or ulcers
Root Cause:
Autoimmune-mediated vasculitis affecting small- to medium-sized blood vessels, leading to inflammation and necrosis in multiple organs, particularly the kidneys, lungs, and upper respiratory tract.
How it's Diagnosed: videos
Diagnosis involves clinical assessment, laboratory tests (e.g., ANCA test, ESR, CRP), imaging studies (e.g., CT or MRI), and tissue biopsy of affected organs (commonly kidney or nasal tissues).
Treatment:
Treatment focuses on inducing and maintaining remission with immunosuppressive therapy and supportive care.
Medications:
Commonly prescribed medications include - Glucocorticoids (e.g., prednisone ) to reduce inflammation. Immunosuppressants (e.g., cyclophosphamide or methotrexate ) to control autoimmune activity. Biologics such as rituximab , a monoclonal antibody targeting B-cells. Plasma Exchange in severe cases with kidney or lung involvement.
Prevalence:
How common the health condition is within a specific population.
Rare; estimated incidence is 1 in 20,000–30,000 people, with equal distribution across genders and a peak onset between ages 40–65.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Genetic predisposition, environmental triggers (e.g., infections), and possibly silica dust exposure.
Prognosis:
The expected outcome or course of the condition over time.
Prognosis has improved with treatment, with remission achieved in most cases, but relapses are common; untreated, it can be fatal within a year.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Kidney failure, pulmonary hemorrhage, chronic sinusitis, hearing loss, secondary infections due to immunosuppression.
Scleroderma Renal Crisis
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Symptoms:
severe hypertension; acute kidney injury; headaches; seizures; blurred vision; shortness of breath; fluid retention
Root Cause:
Vascular injury and narrowing of the renal arteries due to systemic sclerosis lead to decreased renal perfusion, activating the renin-angiotensin system and causing a hypertensive crisis.
How it's Diagnosed: videos
Clinical presentation (acute hypertension and renal dysfunction), lab tests (elevated serum creatinine, proteinuria), and kidney biopsy (if necessary).
Treatment:
Aggressive blood pressure control, primarily with angiotensin-converting enzyme (ACE) inhibitors, supportive care for kidney function, and possibly dialysis.
Medications:
ACE inhibitors (e.g., captopril , enalapril ) are the primary treatment. They are antihypertensive medications that inhibit the renin-angiotensin system to lower blood pressure and protect kidney function.
Prevalence:
How common the health condition is within a specific population.
Occurs in approximately 5–10% of patients with systemic sclerosis.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Diffuse systemic sclerosis, anti-RNA polymerase III antibodies, recent use of high-dose corticosteroids.
Prognosis:
The expected outcome or course of the condition over time.
With prompt treatment, prognosis has improved, but long-term outcomes depend on kidney function recovery. Untreated cases may lead to irreversible kidney damage or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease, end-stage renal disease, hypertensive encephalopathy, heart failure.
Sarcoidosis with Renal Manifestations
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Sub-category: Granulomatous Disorders
Symptoms:
hypercalcemia; nephrolithiasis (kidney stones); renal failure; polyuria; polydipsia; fatigue
Root Cause:
Granulomatous inflammation in sarcoidosis leads to dysregulated calcium metabolism and deposition, as well as granuloma formation in the kidneys, impairing renal function.
How it's Diagnosed: videos
Lab tests (elevated serum and urinary calcium, elevated angiotensin-converting enzyme levels), kidney biopsy (granulomas), and imaging (renal ultrasound, CT scan).
Treatment:
Corticosteroids to suppress granulomatous inflammation, hydration to prevent hypercalcemia, and management of complications like kidney stones or chronic kidney disease.
Medications:
Prednisone (a corticosteroid) is the primary treatment. It is an anti-inflammatory medication that suppresses granuloma formation and reduces calcium abnormalities.
Prevalence:
How common the health condition is within a specific population.
Sarcoidosis affects 1–5% of the population, with renal involvement in approximately 20–30% of cases.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
African descent, family history of sarcoidosis, female gender, environmental exposures.
Prognosis:
The expected outcome or course of the condition over time.
Prognosis depends on the extent of renal involvement; early treatment can improve outcomes, but chronic kidney disease may develop in severe cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease, end-stage renal disease, nephrocalcinosis, recurrent kidney stones.
Rheumatoid Arthritis (Secondary Amyloidosis)
Specialty: Nephrology
Category: Systemic Diseases with Renal Involvement
Sub-category: Inflammatory and Autoimmune Disorders
Symptoms:
proteinuria; edema; fatigue; weight loss; joint pain and swelling
Root Cause:
Chronic inflammation in rheumatoid arthritis leads to deposition of amyloid A protein in the kidneys, causing structural damage and dysfunction.
How it's Diagnosed: videos
Lab tests (elevated serum amyloid A protein, proteinuria, renal function tests), kidney biopsy (amyloid deposits confirmed with Congo red staining).
Treatment:
Controlling the underlying rheumatoid arthritis with anti-inflammatory and disease-modifying drugs, alongside supportive treatment for kidney dysfunction.
Medications:
Biological agents (e.g., TNF inhibitors like adalimumab or etanercept ), methotrexate (a disease-modifying anti-rheumatic drug), and supportive medications like diuretics for fluid retention.
Prevalence:
How common the health condition is within a specific population.
Secondary amyloidosis occurs in 5–10% of patients with long-standing, poorly controlled rheumatoid arthritis.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Severe, chronic rheumatoid arthritis, poor disease control, male gender, older age.
Prognosis:
The expected outcome or course of the condition over time.
With effective treatment of rheumatoid arthritis, the progression of amyloidosis can be slowed, but established renal damage may be irreversible.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic kidney disease, nephrotic syndrome, heart failure due to systemic amyloidosis, infections.